CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- 4 Shares withheld for taxes Vice President of Finance gave up 206 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 999 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 2,361 shares (to pay taxes)
- 10-Q Report Quarterly Report
- 4 Shares withheld for taxes Vice President of Finance gave up 343 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 986 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 1,146 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 2,751 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 5,576 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 12,657 shares (to pay taxes)
- 4 Shares withheld for taxes Vice President of Finance gave up 4,951 shares (to pay taxes)
- 8-K Event Delisting notice
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 999 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 2,361 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 876 shares (to pay taxes)
- 10-Q/A Report 10-Q/A
Page 13 of 24 · 464 filings